Obesity Trial, Recruiting (NCT05798676)

Obesity Trial, Recruiting NCT05798676 Sponsor: Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri Condition: Obesity

Printed from Voxsanity (voxsanity.com.au) — NCT05798676 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Obesity

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Women who are currently breastfeeding and who had a normal, overweight, or obese body weight before becoming pregnant, based on World Health Organization definitions

Who may not be able to join:

Women who have Type 1 diabetes, Type 2 diabetes, or diabetes that developed during pregnancy
Women who were pregnant with more than one baby (such as twins or triplets)
Women who had high blood pressure conditions during pregnancy
Women whose baby was born early, before 37 weeks of pregnancy

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Maria F Andreoli, BsC, Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri

Phone: 54 221 4535901

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05798676

Sponsor: Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri

Phase: Not Applicable

Status: Recruiting

Condition: Obesity

Trial contact: 54 221 4535901

More information: https://clinicaltrials.gov/study/NCT05798676

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Women who are currently breastfeeding and who had a normal, overweight, or obese body weight before becoming pregnant, based on World Health Organization definitions

Who may not be able to join:

Women who have Type 1 diabetes, Type 2 diabetes, or diabetes that developed during pregnancy
Women who were pregnant with more than one baby (such as twins or triplets)
Women who had high blood pressure conditions during pregnancy
Women whose baby was born early, before 37 weeks of pregnancy

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri

Registry

ClinicalTrials.gov

Start date

2 May 2019

Est. completion

1 March 2028

Where this trial is recruiting

🇦🇷 Argentina

Primary endpoints

infant weight; infant height; infant body mass index (BMI); infant upper arm circumference; infant skinfold thickness; infant blood leptin concentration; infant blood cortisol concentration; infant saliva cortisol concentration; infant blood insulin concentration; infant insulin receptor gene expression in peripheral blood mononuclear cells; infant leptin receptor gene expression in peripheral blood mononuclear cells; infant glucocorticoid receptor gene expression in peripheral blood mononuclear cells; infant blood LEAP2 concentration; infant eating behavior assessed in a Taste acceptance test

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov